Atrium Therapeutics (RNA) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.9
-0.82
-0.73
-0.65

Details

Expected EPS
-0.875495
Actual EPS
-0.9
Surprise EPS
-0.02
Surprise Percent
-2.8%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-0.9⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts